Related Experiment Videos
Deficiency of prostacyclin production in meningococcal shock
R S Heyderman1, N J Klein, G I Shennan
1Infectious Diseases Unit, Hospitals for Sick Children, London.
Abstract:
A deficiency of prostacyclin (PGI2) production by the vascular endothelium might underline the severe vasoconstriction and intravascular thrombosis that characterise meningococcal shock. The effect on PGI2 synthesis by human umbilical vein endothelial cells (HUVEC) in culture was examined in sera from children with meningococcal shock, healthy adults, and children with other febrile illnesses. In comparison with adult controls, PGI2 synthesis was reduced when HUVEC were incubated with the sera from 10 of 13 patients with meningococcal shock. A similar defect was observed with only four of 20 sera from children with other febrile illnesses. The effect of sera from patients with meningococcal shock on HUVEC was reversible with normal serum, and seems to be due to the absence of a factor necessary for PGI2 production rather than an inhibitor. These findings suggest that a deficiency of PGI2 may have a role in the pathogenesis of meningococcal shock and that exogenous PGI2 may be of therapeutic benefit.
Insights
Meningococcal shock may stem from reduced prostacyclin (PGI2) production. This study found lower PGI2 synthesis in endothelial cells exposed to patient sera, suggesting PGI2 deficiency in meningococcal shock pathogenesis.
Area of Science:
- Vascular biology
- Immunology
- Pediatric critical care
Background:
- Meningococcal shock involves severe vasoconstriction and thrombosis.
- Prostacyclin (PGI2) is a key regulator of vascular tone and platelet aggregation.
- Endothelial PGI2 production may be impaired in meningococcal shock.
Purpose of the Study:
- To investigate the effect of sera from children with meningococcal shock on prostacyclin (PGI2) synthesis by human umbilical vein endothelial cells (HUVEC).
- To determine if a deficiency in PGI2 production is a characteristic feature of meningococcal shock.
- To explore the potential therapeutic role of PGI2 in meningococcal shock.
Main Methods:
- Human umbilical vein endothelial cells (HUVEC) were cultured in vitro.
- HUVEC were incubated with sera from children with meningococcal shock, healthy adults, and children with other febrile illnesses.
- Prostacyclin (PGI2) synthesis by HUVEC was measured.
Main Results:
- Sera from 10 out of 13 patients with meningococcal shock significantly reduced PGI2 synthesis by HUVEC compared to adult controls.
- A similar defect in PGI2 synthesis was observed in only 4 out of 20 sera from children with other febrile illnesses.
- The inhibitory effect of meningococcal shock sera was reversible with normal serum, indicating a deficiency of a necessary factor rather than an inhibitor.
Conclusions:
- A deficiency in endothelial prostacyclin (PGI2) production may contribute to the pathogenesis of meningococcal shock.
- The findings suggest that exogenous PGI2 could be a potential therapeutic agent for meningococcal shock.
- Further research is warranted to confirm the role of PGI2 deficiency and its therapeutic implications.